Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 20INDUSTRY 3NIH 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 12Other hematologic neoplasm 11Breast 11Classical hematology 4Thoracic 3Plasma cell 3Other solid neoplasm 3Myeloid 3Sarcoma 2Gastrointestinal 2Dermatologic 1CNS 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Solid Tumors 1Advanced Solid Tumors 1

Interventions

Injections 98pembrolizumab 90Carboplatin 57Paclitaxel 54Cisplatin 52Nivolumab 44Docetaxel 43Pemetrexed 42Gemcitabine 37atezolizumab 32tislelizumab 29Bevacizumab 29toripalimab 23Fluorouracil 23Capecitabine 23Irinotecan 22Oxaliplatin 20durvalumab 19Ipilimumab 18Leucovorin 17Cetuximab 17Rifampin 14Itraconazole 14olaparib 13spartalizumab 12Midazolam 12Cyclophosphamide 12trifluridine tipiracil drug combination 11sintilimab 11Drug Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Filgrastim × Other solid neoplasm × Clear all
NCT00462358 2020-09-28

A Study of ARRY-520 in Patients With Advanced Cancer

Array BioPharma

Phase 1 Completed
41 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT01940601 2015-01-14

Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors

Teva Branded Pharmaceutical Products R&D, Inc.

Phase 2 Withdrawn
Other solid neoplasm

Solid Tumors

NCT00616213 2011-06-01

PR104 and G-CSF in Treating Patients With Solid Tumors

Proacta, Incorporated

Phase 1 Completed
5 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡